首页 | 本学科首页   官方微博 | 高级检索  
     

聚乳酸作为骨形态发生蛋白载体修复骨缺损的实验研究
引用本文:谭祖键,李起鸿,许建中. 聚乳酸作为骨形态发生蛋白载体修复骨缺损的实验研究[J]. 中华骨科杂志, 2000, 20(12): 742-746
作者姓名:谭祖键  李起鸿  许建中
作者单位:第三军医大学附属西南医院骨科,重庆
摘    要:目的 探讨聚乳酸(polyldac acid,PLA)作为骨形态发生蛋白(bon e morphogenetic pro-tein,BMP)载体的可行性及观察其诱导成骨能力。方法 手术造成日本大耳白兔左尺骨中上段12mm骨缺损实验模型。随机分为实验。对照及空白组,实验组植入以PLA为载体的BMP10mg、对照组植入以牛松质骨基质为载体的BMP10mg、空白组不做任何处理,术后摄X线片观察各组不同时相骨缺损修复情况,并于术后第4、8、12周观察各组缺损内组织学变化。图像分析骨小梁的生成量。结果 实验修复情况优于对照组,无论是骨连接发生时间还是骨成熟时间,实验组均较对照组提前2周左右,同期骨生成量也明显多于对照组,而空白组缺损内主要形成纤维组织。结论 PLA可以作为BMP的载体修复骨缺损,它比异种松质骨基质载体的成骨效

关 键 词:骨形态发生蛋白 骨缺损 BMP载体 聚乳酸
修稿时间::

Anexperimental study of bone defects repaired with bone morphogenetic protein usingpolylactic acid as carrier
TAN Zujian,LI Qihong,XU Jianzhong,et al.. Anexperimental study of bone defects repaired with bone morphogenetic protein usingpolylactic acid as carrier[J]. Chinese Journal of Orthopaedics, 2000, 20(12): 742-746
Authors:TAN Zujian  LI Qihong  XU Jianzhong  et al.
Affiliation:TAN Zujian,LI Qihong,XU Jianzhong,et al. Department of Orthopaedics,Southwest Hospital,Third Military Medical University,Chongqing 400038,China
Abstract:Objective To study the feasibility of polylactic acid(PLA) as carrier of bone morphogenetic protein(BMP), and observe its results of inducing osteogenesis. Methods A 12 mm bone defect experimental model in the left ulna of rabbits was made, the animals were divided into three groups at random, bovine BMP 10 mg with PLA carrier was implanted into the defect area in the experimental group, bovine BMP 10 mg with bovine cancellous bone matrix carrier was implanted in the control group, and nothing was implanted in the blank group. The osteogenesis of the bone in the defect area was observed by regular roentgenography, the histological changes of the bone defect tissue in 4th, 8th, 12th week after operation were studied and the new bone formation was measured by image analysis. Results The results revealed that the bone defect in the experimental group had excellent repair than that seen in the control and blank group, both bone union and the period of bone mature were earlier than that seen in the control and blank groups. There was fibration in the blank group at 12th week. Conclusion The result indicated that PLA is a material able to be used as a carrier of BMP in inducing osteogenesis, it has a better effect of inducing osteogenesis than xenogenous cancellous bone matrix. Compared with other carriers, PLA has the following advantages: 1)It releases BMP gradually during degradation, so the BMP concentration in bone defect can be maintained effectively. 2)It is a material with some rigidity, so is able to exert flexible fixation of the fractures. 3)It can be shaped to adjust itself for the individual fractures. 4)It has a good histocompatibility and an adjustable property. However, the relationship between the molecule weight, aperture of PLA and the best inducing osteogenesis need a further study.
Keywords:Polyglactin 910  Bone morphogenetic proteins  Drug carriers
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号